NCT00987545View on ClinicalTrials.gov

Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Keloids
Interventions
DRUG

QAX576

QAX576 injection

DRUG

QAX576 placebo

Placebo to QAX576 injection

Trial Locations (4)

14623

Skin Search of Rochester/Dermatology Associates, Rochester

23507

Virginia Clinical Research, Inc., Norfolk

27262

Dermatology Consulting Services, High Point

07652

TKL Research, Inc, Paramus

Sponsors
All Listed Sponsors
collaborator

TKL Research, Inc.

INDUSTRY

collaborator

Dermatology Consulting Services, High Point NC

OTHER

collaborator

Skin Search

UNKNOWN

collaborator

Virginia Clinical Research, Inc.

OTHER

lead

Novartis Pharmaceuticals

INDUSTRY